Inbio Ventures

Investor type

VC

Founded

2013

AUM

$300 M

Location

Russia

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Series B

Investment Stage

Acquisition

Exit Strategy

Profile

Over $200m deployed in early stage biotech companies through investments and strategic deals. 360˚ knowledge of the sector. Evolution stages: Academia, In-house Industrial R&D, Corporate VC and Business Development, Professional Regulated Public Equities Asset Management. Top positions in venture and production biotech companies in USA, Russia, Canada, EU: Pharmstandard, Generium, Aquinox, Protagonist, Codon, Allena, Transmedics and others Inbio ventures is looking for innovative drug discovery/development projects targeting the unmet medical needs or providing dramatic advantages over the competition globally.
Therapeutic areas of the highest priority are the following:
-Oncology
-Inflammation
-Autoimmune diseases
-Orphan genetic diseases
-Critical care
-Cell-based therapy and regenerative medicine
-Stage of development

The project, ideally, should at least have passed the in-vivo proof-of-concept (PoC), and should have a strong scientific background behind it. Management team with appropriate experience is a substantial advantage.

Industry

Pharmaceuticals Biotechnology Healthcare Services Medical Devices MedTech Technology Life Sciences

Region of investment

North America Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
0KLzgrVHXmUxB2Wl Investment Director
Investment Director
avatar
0KLzgrVHXmUxB2Wl CEO, Partner
CEO, Partner
avatar
0KLzgrVHXmUxB2Wl Managing Partner
Managing Partner
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!